Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis
Abstract
Authors
E Arthurs T Ward O Darlington D Sugrue AA Martin SE Cartier A Lee DL Becker YS Punekar P McEwan